These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4785855)

  • 21. The morphogenesis of experimentazl fascioliasis.
    Poljakova-Krusteva O; Kruster L; Ellis DS; Bird RG
    J Helminthol; 1968; 42(3):367-72. PubMed ID: 5701791
    [No Abstract]   [Full Text] [Related]  

  • 22. Acquired resistance to Fasciola hepatica in sheep.
    Sinclair KB
    Br Vet J; 1971 Mar; 127(5):125-36. PubMed ID: 5548516
    [No Abstract]   [Full Text] [Related]  

  • 23. Fasciola hepatica: bile duct enlargement induced in rats after intraperitoneal transplantation.
    Isseroff H; Girard PR; Leve MD
    Exp Parasitol; 1977 Apr; 41(2):405-9. PubMed ID: 849766
    [No Abstract]   [Full Text] [Related]  

  • 24. Schistosoma mansoni and Fasciola hepatica: cross-resistance in mice with single-sex schistosome infections.
    Christensen NO; Monrad J; Nansen P; Frandsen F
    Exp Parasitol; 1980 Feb; 49(1):116-21. PubMed ID: 7349999
    [No Abstract]   [Full Text] [Related]  

  • 25. Proteases and their inhibitors involved in Schistosoma mansoni egg-host interaction revealed by comparative transcriptomics with Fasciola hepatica eggs.
    Peterkova K; Vorel J; Ilgova J; Ostasov P; Fajtova P; Konecny L; Chanova M; Kasny M; Horn M; Dvorak J
    Int J Parasitol; 2023 May; 53(5-6):253-263. PubMed ID: 36754342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on emetine, an 'acute' fasciolicide.
    Grant MS; Jaggers SE
    Res Vet Sci; 1969 Mar; 10(2):197-202. PubMed ID: 5818036
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunoexpression of intermediate filaments and morphological changes in the liver and bile duct of rats infected with Fasciola hepatica.
    Kolodziejczyk L; Laszczyńska M; Masiuk M; Grabowska M; Skrzydlewska E
    Biotech Histochem; 2015; 90(7):477-85. PubMed ID: 25923046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the pathogenicity of massive infections of Fasciola hepatica L. in lambs.
    Pullan NB; Sewell MM; Hammond JA
    Br Vet J; 1970 Oct; 126(10):543-58. PubMed ID: 5491591
    [No Abstract]   [Full Text] [Related]  

  • 29. Resistance to Fasciola hepatica in sheep harbouring primary Schistosoma bovis infections.
    Monrad J; Christensen NO; Nansen P; Frandsen F
    J Helminthol; 1981 Dec; 55(4):261-71. PubMed ID: 7310108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The course of an experimental liver fluke infection in the pig.
    Nansen P; Andersen S; Harmer E
    Acta Vet Scand; 1974; 15(1):138-40. PubMed ID: 4830065
    [No Abstract]   [Full Text] [Related]  

  • 31. On the ultrastructure of mast cells and globule leucocytes in the common bile duct of cattle chronically infected with fasciola hepatica.
    Rahko T
    Acta Vet Scand; 1973; 14(2):245-53. PubMed ID: 4728105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver-fluke infestation (Fasciola hepatica).
    Bhambal SS; Bhandari NR; Bajpai R
    Indian Pediatr; 1980 May; 17(5):469-71. PubMed ID: 7461846
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of myrrh (Mirazid) therapy in fascioliasis and intestinal schistosomiasis in children: immunological and parasitological study.
    Soliman OE; El-Arman M; Abdul-Samie ER; El-Nemr HI; Massoud A
    J Egypt Soc Parasitol; 2004 Dec; 34(3):941-66. PubMed ID: 15587320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rat-like hamster, Tscherskia triton, as a host for the parthenogenetic liver fluke Fasciola sp.
    Terasaki K; Noda Y; Itagaki T; Shibahara T; Tsuchiya K; Fukuda K; Inoue Y; Iwamura M; Hino A
    J Parasitol; 2002 Oct; 88(5):1035-7. PubMed ID: 12435155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the anaemia of chronic ovine fascioliasis.
    Sinclair KB
    Res Vet Sci; 1972 Mar; 13(2):182-4. PubMed ID: 4537640
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fasciola hepatica (apropos of a case)].
    Miras Estacio M; del Pozo Camarón A; Serrano Sánchez PA; Marrón C; Piñeiro MM; Pajares JM
    Rev Esp Enferm Apar Dig; 1981 Jan; 59(1):99-106. PubMed ID: 7209102
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fasciola hepatica antigens. Use in the diagnosis of human fascioliasis].
    Espino Hernández AM; Seuret N; Morlote C; Duménigo Ripoll B
    Rev Cubana Med Trop; 1991; 43(3):151-5. PubMed ID: 9768179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fasciola hepatica: the sonographic and computed tomographic changes in a case with a liver fluke].
    Brenner-Maucher K; Szeimies U; Mannstadt M; Gross M
    Rofo; 2000 Jun; 172(6):562-3. PubMed ID: 10916555
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini.
    Keiser J; Shu-Hua X; Chollet J; Tanner M; Utzinger J
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1096-8. PubMed ID: 17194822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on experimental infections with Fasciola hepatica, with particular reference to acute fascioliasis in sheep.
    Boray JC
    Ann Trop Med Parasitol; 1967 Dec; 61(4):439-50. PubMed ID: 5634134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.